Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00981994
Other study ID # 5R01CI000611
Secondary ID
Status Completed
Phase N/A
First received September 14, 2009
Last updated November 23, 2016
Start date October 2009
Est. completion date September 2012

Study information

Verified date November 2016
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Inappropriate use of antibiotics to treat patients with acute bronchitis is a significant factor contributing to the selection of antimicrobial drug resistant pathogens, which threaten the effectiveness of available therapies to treat common community-acquired bacterial infections. A key factor driving overuse of antibiotics is inaccurate estimation of pneumonia risk among patients with acute cough illnesses. This study will use a cluster randomized trial design within the Geisinger Health System's integrated clinic network to measure the efficacy of an algorithm driven clinical decision support tool to safely reduce the frequency of unnecessary antibiotic prescriptions for adult patients with lower respiratory tract infections.


Description:

The rapid rise in antibiotic resistance among common bacteria are adversely affecting the clinical course and health care costs of community-acquired infections. Because antibiotic resistance patterns are strongly correlated with antibiotic use patterns, multiple organizations have declared reductions in unnecessary antibiotic use to be critical components of efforts to combat antibiotic resistance. Among humans, the vast majority of unnecessary antibiotic prescriptions are used to treat acute respiratory tract infections (ARIs) that have a viral etiology. In particular, despite the fact that numerous controlled trials have demonstrated no benefit of antibiotic therapy for patients with acute bronchitis, the majority of patients diagnosed with acute bronchitis continue to receive antibiotic therapy across diverse treatment settings. Recently, the National Committee on Quality Assurance adopted the proportion of adult visits diagnosed as acute bronchitis when an antibiotic was NOT prescribed as a quality measure within the HEDIS data set. Recent results from the HEDIS dataset emphasize the continued high rates of antibiotic prescribing for patients with acute bronchitis. One key factor driving overuse of antibiotics in the management of patients with lower respiratory tract infections—such as acute bronchitis—is diagnostic uncertainty and inaccurate risk estimation of underlying pneumonia in such patients. Recently, our study team has observed substantial reductions in antibiotic prescribing following the incorporation of a diagnostic and treatment algorithm into an acute care setting. This acute cough management algorithm incorporates data on vital signs and symptoms distinguishing patients with community-acquired pneumonia from other patients with acute cough illness, specifically those with acute bronchitis. The acute cough management algorithm has become even more valuable in recent years due to the introduction of quality measures that emphasize the timely administration of antibiotics for patients with community-acquired pneumonia. Thus, strong empirical evidence of the effectiveness of such an algorithm could lead to wide adoption of the algorithm and substantial improvements in antibiotic prescribing. The investigative team is proposing a unique partnership with Geisinger Health System, a large integrated health network, to implement and evaluate the algorithm. Utilizing a cluster-randomized trial design across 33 practice sites, we will address the following aims: 1) To measure the reduction in antibiotic prescribing resulting from incorporation of the algorithm compared to usual care sites utilizing two different implementation strategies, one poster-based and one electronic health record-based, 2) To measure revisits, delayed hospitalizations and net economic costs associated with algorithm implementation, and 3) To evaluate local practice characteristics influencing the level of implementation and ultimate performance success at intervention sites. In a final component of the study, the investigators will partner with NCQA to disseminate study results through the national network of participating plans and stimulate wide spread adoption of the algorithm and quality improvement methods.


Recruitment information / eligibility

Status Completed
Enrollment 3300
Est. completion date September 2012
Est. primary completion date May 2011
Accepts healthy volunteers No
Gender Both
Age group 16 Years and older
Eligibility Inclusion Criteria:

- Primary care practice sites within the Geisinger Health System

Exclusion Criteria:

- Sites with < 1000 visits per year for acute respiratory infection

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Decision Support for ARI Management
Use of history and physical examination findings to estimate probability of pneumonia in patients with acute respiratory infections and thereby guide treatment decisions

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
University of Pennsylvania Geisinger Clinic, University of California, San Francisco

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of visits to primary care clinic associated with antibiotic prescriptions 30 days No
See also
  Status Clinical Trial Phase
Recruiting NCT04476680 - Influence of Military Preventive Policy for reCruit Training on COVID-19 Seroconversion N/A
Active, not recruiting NCT05127161 - Broad Implementation of Outpatient Stewardship N/A
Completed NCT04579640 - Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections Phase 3
Completed NCT01133782 - Clinical Application of PCR-based Diagnosis of Community-onset Viral Respiratory Infections. N/A
Completed NCT04663776 - Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform
Suspended NCT05175612 - Differentiation of Upper and Lower Respiratory Tract Infections Using Automated Lung Sound Analysis With LungPass Device
Not yet recruiting NCT03674775 - Reducing Antibiotic Prescribing in Family Practice N/A
Recruiting NCT06278324 - Effectiveness of a Nasal Spray on Viral Respiratory Infections N/A
Completed NCT03379194 - Routine Antibiotic Prescription Monitoring in Primary Care Physicians: A Nationwide Trial N/A
Withdrawn NCT04216277 - The Procalcitonin Guided Antibiotics in Respiratory Infections in General Practice N/A
Not yet recruiting NCT06282718 - A Long-term Observational Study Evaluating the Presentation and Management of Acute Respiratory Tract Infections in Primary Care Across Europe
Completed NCT00272116 - Effect of Zinc and Vitamin A Supplementation on Diarrhea, Physical Growth and Immune Response in Malnourished Children N/A
Completed NCT04346693 - An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19 Phase 3
Not yet recruiting NCT05814237 - POS-ARI-ER Observational Study of Acute Respiratory Infections
Completed NCT05090475 - Implementation of Academic Detailing Interventions on Prescribing of Antimicrobial Drugs in Primary Health Care N/A